Clinical Trial Update: TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating tranexamic acid to prevent blood loss after cesarean delivery in women with placenta previa; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Postpartum Hemorrhage | Phase 3 | Status: RECRUITING